Загрузка...
AB 26. Comparison of pharmacokinetics of Moxifloxacin between patients with drug-resistant and multi-drug resistant pulmonary tuberculosis
BACKGROUND: Moxifloxacin is a potent bactericidal and sterilizing antitubercular drug that is currently used as part of the therapeutic regimen in cases of drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB). According to previous reports rifampicin reduces Moxifloxacin levels by 30...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Pioneer Bioscience Publishing Company
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537437/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s026 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|